Amgen Inc. buy Royal Bank of Canada
Start price
07.04.26
/
50%
€292.40
Target price
07.04.27
€320.90
Performance (%)
9.22%
Price
30.06.26
€316.85
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 9.22%. Dividends of €2.52 are taken into consideration when calculating the performance. This prediction currently runs until 07.04.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 3.953% | 3.953% |
| iShares Core DAX® | 0.365% | -0.242% |
| iShares Nasdaq 100 | 2.592% | 1.795% |
| iShares Nikkei 225® | 1.801% | 7.119% |
| iShares S&P 500 | 1.205% | 0.930% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen (AMGN) had its price target raised by Royal Bank Of Canada from $360.00 to $370.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat